RESULT OF CLINICAL TRIALS FOR LAGUNDI TO BE RELEASE IN 2 MONTHS
The Department of Science and Technology said that the results of clinical trials for lagundi as COVID-19 treatment for patients with mild symptoms may be out after two months.
The Food and Drug Administration approved lagundi at supplemental treatment for COVID-19.
The clinical trials will be done at Sta. Ana Hospital, Quezon Institute Quarantine Center, and Philippine National Police-National Capital Region Community Quarantine Center.
Tawa-Tawa is also authorized as a herbal supplement for COVID-19 but still waiting for the FDA’s approval.